Abacus Health Products Competitors

Abacus Health Products (OTCMKTS:ABAHF) and Acreage (OTCMKTS:ACRGF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation and analyst recommendations.

Profitability

This table compares Abacus Health Products and Acreage's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent ratings and price targets for Abacus Health Products and Acreage, as provided by MarketBeat.

Acreage has a consensus price target of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher probable upside, analysts plainly believe Acreage is more favorable than Abacus Health Products.

Valuation and Earnings

This table compares Abacus Health Products and Acreage's top-line revenue, earnings per share (EPS) and valuation.

Summary

Acreage beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Profitability

This table compares Applied Biosciences and Abacus Health Products' net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current ratings for Applied Biosciences and Abacus Health Products, as reported by MarketBeat.

Valuation and Earnings

This table compares Applied Biosciences and Abacus Health Products' gross revenue, earnings per share (EPS) and valuation.

Ayr Strategies (OTCMKTS:AYRSF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, dividends, earnings, institutional ownership and risk.

Valuation and Earnings

This table compares Ayr Strategies and Abacus Health Products' gross revenue, earnings per share (EPS) and valuation.

Analyst Recommendations

This is a breakdown of current ratings for Ayr Strategies and Abacus Health Products, as reported by MarketBeat.

Ayr Strategies presently has a consensus target price of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher probable upside, equities research analysts plainly believe Ayr Strategies is more favorable than Abacus Health Products.

Profitability

This table compares Ayr Strategies and Abacus Health Products' net margins, return on equity and return on assets.

Summary

Ayr Strategies beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Abacus Health Products (OTCMKTS:ABAHF) and Can B (NASDAQ:CANB) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Valuation & Earnings

This table compares Abacus Health Products and Can B's gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a summary of current recommendations and price targets for Abacus Health Products and Can B, as reported by MarketBeat.com.

Profitability

This table compares Abacus Health Products and Can B's net margins, return on equity and return on assets.

Abacus Health Products (OTCMKTS:ABAHF) and Cansortium (OTCMKTS:CNTMF) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Profitability

This table compares Abacus Health Products and Cansortium's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations and price targets for Abacus Health Products and Cansortium, as reported by MarketBeat.com.

Cansortium has a consensus target price of $1.20, suggesting a potential upside of 49.16%. Given Cansortium's higher probable upside, analysts plainly believe Cansortium is more favorable than Abacus Health Products.

Valuation & Earnings

This table compares Abacus Health Products and Cansortium's gross revenue, earnings per share (EPS) and valuation.

Summary

Cansortium beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.

Charlotte's Web (OTCMKTS:CWBHF) and Abacus Health Products (OTCMKTS:ABAHF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, earnings, valuation, dividends, institutional ownership, profitability and risk.

Profitability

This table compares Charlotte's Web and Abacus Health Products' net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of recent ratings and price targets for Charlotte's Web and Abacus Health Products, as provided by MarketBeat.

Charlotte's Web presently has a consensus price target of $7.80, suggesting a potential upside of 61.32%. Given Charlotte's Web's higher possible upside, equities research analysts clearly believe Charlotte's Web is more favorable than Abacus Health Products.

Valuation and Earnings

This table compares Charlotte's Web and Abacus Health Products' revenue, earnings per share and valuation.

Summary

Charlotte's Web beats Abacus Health Products on 2 of the 2 factors compared between the two stocks.